WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.94 Billion CNY | -9.6% |
| 2022 | 4.35 Billion CNY | 37.23% |
| 2021 | 3.17 Billion CNY | 111.01% |
| 2020 | 1.5 Billion CNY | 58.48% |
| 2019 | 947.96 Million CNY | 81.47% |
| 2018 | 522.37 Million CNY | 27.19% |
| 2017 | 410.69 Million CNY | 103.78% |
| 2016 | 201.53 Million CNY | 223.87% |
| 2015 | 62.22 Million CNY | 17.82% |
| 2014 | 52.81 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.81 Billion CNY | 0.0% |
| 2023 Q4 | 1.64 Billion CNY | 0.0% |
| 2023 FY | 3.93 Billion CNY | -9.6% |
| 2023 Q2 | 2.3 Billion CNY | 0.0% |
| 2022 FY | 4.35 Billion CNY | 37.23% |
| 2022 Q2 | 2.48 Billion CNY | 0.0% |
| 2022 Q4 | 1.86 Billion CNY | 0.0% |
| 2021 Q4 | 1.52 Billion CNY | 0.0% |
| 2021 Q2 | 1.64 Billion CNY | 0.0% |
| 2021 FY | 3.17 Billion CNY | 111.01% |
| 2020 Q2 | 354.46 Million CNY | 0.0% |
| 2020 FY | 1.5 Billion CNY | 58.48% |
| 2020 Q4 | 1.14 Billion CNY | 0.0% |
| 2019 FY | 947.96 Million CNY | 81.47% |
| 2019 Q4 | 566.9 Million CNY | 0.0% |
| 2019 Q2 | 381.06 Million CNY | 0.0% |
| 2018 FY | 522.37 Million CNY | 27.19% |
| 2018 Q4 | 267.24 Million CNY | 0.0% |
| 2018 Q2 | 255.13 Million CNY | 0.0% |
| 2017 FY | 410.69 Million CNY | 103.78% |
| 2017 Q2 | 163.44 Million CNY | 0.0% |
| 2017 Q4 | 247.24 Million CNY | 0.0% |
| 2016 Q2 | 110.01 Million CNY | 0.0% |
| 2016 Q4 | 115.88 Million CNY | 0.0% |
| 2016 FY | 201.53 Million CNY | 223.87% |
| 2015 Q4 | 14.96 Million CNY | 0.0% |
| 2015 FY | 62.22 Million CNY | 17.82% |
| 2015 Q1 | 14.96 Million CNY | 17.6% |
| 2015 Q2 | 14.96 Million CNY | 0.0% |
| 2015 Q3 | 14.96 Million CNY | 0.0% |
| 2014 Q3 | 12.72 Million CNY | 0.0% |
| 2014 Q1 | 12.72 Million CNY | 0.0% |
| 2014 FY | 52.81 Million CNY | 0.0% |
| 2014 Q4 | 12.72 Million CNY | 0.0% |
| 2014 Q2 | 12.72 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 5601.718% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -80258.39% |
| SQZ Biotechnologies Company | -75.82 Million USD | 5308.655% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 22229.562% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | -4725.133% |
| Mesoblast Limited | -84.14 Million USD | 4793.528% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 257218.295% |
| Genus plc | 6.4 Million USD | -61610.359% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | -40438.667% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 424144.214% |
| Marizyme, Inc. | -34.08 Million USD | 11686.585% |
| ContraFect Corporation | -56.88 Million USD | 7042.402% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 47398.958% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 86811.319% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 281803.877% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 138653.001% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 143673.034% |
| MultiCell Technologies, Inc. | -722.81 USD | 546404134.394% |
| Accustem Sciences Inc. | -3.74 Million USD | 105519.682% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 6795.14% |
| EV Biologics, Inc. | -483.06 Thousand USD | 817689.254% |
| Q BioMed Inc. | -3.44 Million USD | 114722.843% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | -111466.751% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 1013900.601% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 150411.32% |
| Biomind Labs Inc. | -1 Million USD | 391289.705% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 81039.182% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 59508.154% |
| Skye Bioscience, Inc. | -13.67 Million USD | 28987.659% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 198917.254% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | 13186074.229% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 78392.721% |
| IMV Inc. | -38.67 Million USD | 10312.848% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 24986.758% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 204459.027% |
| GB Sciences, Inc. | -1.42 Million USD | 278131.537% |
| Alpha Cognition Inc. | -9.7 Million USD | 40792.617% |
| HST Global, Inc. | -140.9 Thousand USD | 2802986.302% |
| CSL Limited | 3.7 Billion USD | -6.685% |
| Halberd Corporation | -75.05 Thousand USD | 5262542.373% |
| Enzolytics Inc. | -2.14 Million USD | 183898.539% |
| Resverlogix Corp. | -12.74 Million USD | 31078.61% |
| Affymax, Inc. | -15.04 Million USD | 26349.256% |
| SYBLEU INC | -149.18 Thousand USD | 2647548.05% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 124756.611% |
| argenx SE | -425.04 Million USD | 1029.178% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 7215.124% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 378401.054% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 250168.097% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 116090.818% |
| AVAX Technologies, Inc. | 6.69 Million USD | -58909.918% |
| Zenith Capital Corp. | -8.94 Million USD | 44262.619% |
| Genscript Biotech Corporation | -415.79 Million USD | 1049.867% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 22670802.032% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 160953.487% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 2302865.783% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 7284.453% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 136229.703% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 401446.574% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 211939.013% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 314547.691% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 197104.575% |
| BioStem Technologies, Inc. | -7.77 Million USD | 50871.034% |
| ONE Bio Corp. | 13.68 Million USD | -28767.075% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 2176292.523% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 295844.445% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 351192.714% |
| Agentix Corp. | -1.37 Million USD | 288012.938% |
| LadRx Corporation | -3.82 Million USD | 103391.038% |
| Cell Source, Inc. | -4.32 Million USD | 91409.759% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 950680.655% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 575027.287% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 575027.287% |
| NovAccess Global Inc. | -2.46 Million USD | 160207.307% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 135381.341% |
| Itoco Inc. | -919.14 Thousand USD | 429791.124% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 93282.568% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 353045.755% |
| Kadimastem Ltd | -3.04 Million USD | 130005.863% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 1509106.748% |
| CytoDyn Inc. | -18.05 Million USD | 21970.988% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | 15691252.169% |
| Mobile Lads Corp. | -554.55 Thousand USD | 712292.408% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 1794674.197% |
| Qrons Inc. | -643.67 Thousand USD | 613678.394% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 699462.874% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | 177215.574% |
| Rebus Holdings, Inc. | -664 Thousand USD | 594898.645% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 217543.127% |
| International Stem Cell Corporation | -663 Thousand USD | 595795.777% |
| Bioxytran, Inc. | -3.82 Million USD | 103485.105% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 7502879.257% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | 19417322.227% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 10990.264% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 244195.365% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 536832.148% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 127051.559% |
| Neutra Corp. | -229.48 Thousand USD | 1721103.896% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 22618.177% |
| PureTech Health plc | -146.19 Million USD | 2801.43% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 18477.186% |
| IXICO plc | -1.43 Million USD | 274940.849% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 41712.717% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 3342.421% |
| CSL Limited | 3.81 Billion USD | -3.606% |
| Cellectis S.A. | -108.85 Million USD | 3728.109% |